Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Akero Therapeutics, Inc. (AKRO)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 61,281,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Akero Therapeutics is a clinical-stage company developing treatments for patients with serious metabolic diseases, including non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. NASH is a severe form of nonalcoholic fatty liver disease characterized by inflammation and fibrosis in the liver that can progress to cirrhosis, liver failure, cancer and death. Co.'s primary product candidate, efruxifermin, is an analog of fibroblast growth factor 21, which is an endogenously expressed hormone that protects against cellular stress and regulates metabolism of lipids, carbohydrates and proteins throughout the body.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 200,000 800,000 1,200,000
Total Buy Value $0 $3,677,505 $22,531,214 $32,931,214
Total People Bought 0 1 1 1
Total Buy Transactions 0 3 8 9
Total Shares Sold 105,332 171,617 539,059 3,041,073
Total Sell Value $3,452,458 $4,643,441 $23,249,026 $129,057,943
Total People Sold 5 5 7 9
Total Sell Transactions 8 18 44 85
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 303
  Page 1 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Young Jonathan Chief Operating Officer   •       –      –    2024-04-01 4 AS $24.33 $121,913 D/D (5,000) 263,306     -
   Young Jonathan Chief Operating Officer   •       –      –    2024-03-13 4 S $28.33 $18,443 D/D (651) 268,306     -
   White William Richard Chief Financial Officer   •       –      –    2024-03-13 4 S $28.33 $20,511 D/D (724) 49,630     -
   Cheng Andrew President and CEO   •       •      –    2024-03-13 4 S $28.33 $55,782 D/D (1,969) 589,447     -
   Yale Catriona Chief Development Officer   •       –      –    2024-03-13 4 S $28.33 $20,483 D/D (723) 77,692     -
   Rolph Timothy Chief Scientific Officer   •       –      –    2024-03-13 4 S $28.33 $17,536 D/D (619) 182,558     -
   Cheng Andrew President and CEO   •       •      –    2024-03-04 4 AS $31.40 $2,465,063 D/D (75,000) 591,416     -
   Cheng Andrew President and CEO   •       •      –    2024-03-04 4 OE $16.00 $1,288,062 D/D 75,000 666,416     -
   Yale Catriona Chief Development Officer   •       –      –    2024-03-04 4 AS $35.49 $732,727 D/D (20,646) 78,415     -
   Yale Catriona Chief Development Officer   •       –      –    2024-03-04 4 OE $6.36 $288,124 D/D 20,646 99,061     -
   Young Jonathan Chief Operating Officer   •       –      –    2024-03-01 4 OE $0.62 $51,242 D/D 83,321 268,957     -
   Cheng Andrew President and CEO   •       •      –    2024-01-02 4 OE $0.62 $24,600 D/D 40,000 590,911     -
   Young Jonathan Chief Operating Officer   •       –      –    2023-12-27 4 S $24.00 $129,936 D/D (5,414) 185,131     -
   Young Jonathan Chief Operating Officer   •       –      –    2023-12-27 4 OE $6.36 $34,433 D/D 5,414 190,545     -
   Young Jonathan Chief Operating Officer   •       –      –    2023-12-14 4 S $20.76 $11,273 D/D (543) 185,131     -
   White William Richard Chief Financial Officer   •       –      –    2023-12-14 4 S $20.76 $12,684 D/D (611) 50,354     -
   Rolph Timothy Chief Scientific Officer   •       –      –    2023-12-14 4 S $20.76 $10,671 D/D (514) 182,672     -
   Cheng Andrew President and CEO   •       •      –    2023-12-14 4 S $20.76 $33,797 D/D (1,628) 550,911     -
   Yale Catriona Chief Development Officer   •       –      –    2023-12-14 4 S $20.76 $12,394 D/D (597) 77,910     -
   Cheng Andrew President and CEO   •       •      –    2023-12-11 4 AS $20.02 $148,273 D/D (7,405) 552,539     -
   Cheng Andrew President and CEO   •       •      –    2023-12-11 4 OE $6.36 $47,096 D/D 7,405 559,944     -
   Young Jonathan Chief Operating Officer   •       –      –    2023-12-08 4 A $0.00 $0 D/D 32,497 185,674     -
   Lamy Patrick See Remarks   •       –      –    2023-12-08 4 A $0.00 $0 D/D 18,570 18,570     -
   Yale Catriona Chief Development Officer   •       –      –    2023-12-08 4 A $0.00 $0 D/D 32,497 78,507     -
   White William Richard Chief Financial Officer   •       –      –    2023-12-08 4 A $0.00 $0 D/D 32,497 50,965     -
  303 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us